Billionaires
Sergey Brin Backs Startups From Psychedelics to ‘Energy Islands’
- His Catalyst4 nonprofit also funding research into Parkinson’s
- It owns stakes in MapLight Therapeutics, Stellaromics, Soneira
This article is for subscribers only.
Sergey Brin’s climate and health-focused nonprofit bankrolled startups working on everything from psychedelics to an ambitious $155 billion dollar project to build “energy islands” in Copenhagen, a recently released tax filing shows.
The investments, which cover through the end of 2023, reflect the Alphabet Inc. co-founder’s growing appetite to fund research into Parkinson’s disease and other central nervous system diseases and disorders. The 51-year-old billionaire has said he has a genetic mutation that’s been associated with higher rates of Parkinson’s.